Should You Build That AI Feature or Fix Your Core Product?

A pattern has emerged in boardrooms across the software industry. The agenda item reads “AI strategy,” but the underlying conversation is about something older and more fundamental: how to allocate scarce engineering resources between innovation and maintenance, between what's exciting and what's essential.

The pressure to ship AI features is real and, in many cases, legitimate. Customers are asking. Competitors are announcing. Investors are evaluating. But this pressure creates a dangerous asymmetry in organizational attention. AI features generate board slides and press coverage. Fixing a broken onboarding flow or resolving long-standing reliability issues generates neither — even when the latter would deliver significantly more business value.

The Innovation Premium Fallacy

There is a well-documented bias in product organizations toward novel features over foundational improvements. Clayton Christensen observed this dynamic decades ago: incumbents over-invest in sustaining innovations that excite existing customers while neglecting the core reliability that retains them. AI has become the latest vehicle for this bias.

The economics, however, tell a clearer story. For most SaaS businesses, a 5% reduction in churn delivers more enterprise value than a new feature that attracts 5% more trials. The difference is that churn reduction compounds silently while new features create visible momentum. Leaders who allocate resources based on visibility rather than value systematically misallocate.

A Framework for Honest Evaluation

The solution is not to ignore AI — it's to evaluate it with the same rigor applied to any resource allocation decision. This requires asking four questions with genuine intellectual honesty:

What is the measurable business outcome? Not “we'll have an AI feature” but “we expect this to increase trial-to-paid conversion by X%” or “reduce support volume by Y%.” If the outcome can't be quantified, the investment can't be evaluated.

What is our confidence level? Core product improvements — fixing known bugs, streamlining proven workflows — carry high confidence. Novel AI capabilities carry inherently lower confidence. This doesn't make them wrong, but it does affect how they should be sized and sequenced.

What is the cost of deferral? If AI is deferred by one quarter, what is lost? If core product work is deferred, what is lost? Often the asymmetry here is stark: AI features lose novelty; core product neglect loses customers.

What is reversible? A failed AI experiment can be unwound. Customers who leave due to unaddressed core issues rarely return.

A go-to-market strategy tool like Wovly enables product teams to run this analysis systematically — acting as a GTM experiment tracker that evaluates competing initiatives on a common framework of expected impact, confidence, and strategic alignment, so decisions are grounded in evidence rather than enthusiasm.

Strategy, Not Technology

AI is a capability, not a strategy. The companies that will extract the most value from it are the ones that deploy it in service of clearly defined business objectives — not the ones that bolt it on because the market expects it. Sometimes the most strategic thing a product team can do is fix what's broken before building what's shiny.